Crunching the numbers for GILD... Refresh in a moment for the full analysis.
GILEAD SCIENCES, INC. (GILD)
Healthcare
Overvalued
healthy
$140.87
Updated: 2026-04-09
66
TradeApes Score
add
Financial Strength
65
Healthy
Operating Trend
60
Healthy
Valuation
75
Strong
Capital Allocation
50
Mixed
Risk
80
Strong
Fair Value
$11.25
DCF Upside
-92.0%
Sector Rank
#9
of 18
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.